Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - Anzalone Christopher Richard

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for Anzalone Christopher Richard

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-04-03
Sale
2019-04-05
6:57 pm
ARROWHEAD PHARMACEUTICALS Inc ARWR Anzalone Christopher Richard
CEO
50,000 $19.3 $965,000 2,092,455
(Direct)
View
2018-12-19
Sale
2018-12-21
5:15 pm
ARROWHEAD PHARMACEUTICALS Inc ARWR Anzalone Christopher Richard
CEO
90,000 $13.92 $1,252,800 1,542,455
(Direct)
View
2018-12-12
Sale
2018-12-14
5:18 pm
ARROWHEAD PHARMACEUTICALS Inc ARWR Anzalone Christopher Richard
CEO
90,000 $14.07 $1,266,300 1,632,455
(Direct)
View
2018-11-09
Sale
2018-11-09
7:01 pm
ARROWHEAD PHARMACEUTICALS Inc ARWR Anzalone Christopher Richard
CEO
81,500 $14.39 $1,172,705 1,727,755
(Direct)
View
2018-08-31
Sale
2018-09-05
4:23 pm
ARROWHEAD PHARMACEUTICALS Inc ARWR Anzalone Christopher Richard
CEO
164,834 $14.45 $2,381,851 1,868,789
(Direct)
View
2018-03-16
Sale
2018-03-16
6:09 pm
ARROWHEAD PHARMACEUTICALS Inc ARWR Anzalone Christopher Richard
CEO
26,000 $7.4 $192,400 1,968,789
(Direct)
View
2018-03-13
Sale
2018-03-15
6:58 pm
ARROWHEAD PHARMACEUTICALS Inc ARWR Anzalone Christopher Richard
CEO
300,000 $7.427 $2,228,000 2,194,789
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-05-24
Exercise
2019-05-29
6:57 pm
N/A
N/A
ARROWHEAD PHARMACEUTICALS Inc ARWR Anzalone Christopher Richard
CEO
40,072 $2.01 2,141,903
(Direct)
View
2019-05-24
Exercise
2019-05-29
6:57 pm
N/A
N/A
ARROWHEAD PHARMACEUTICALS Inc ARWR Anzalone Christopher Richard
CEO
9,376 $2.62 2,141,903
(Direct)
View
2019-05-24
Exercise
2019-05-29
6:57 pm
2013-06-01
2023-05-06
ARROWHEAD PHARMACEUTICALS Inc ARWR Anzalone Christopher Richard
CEO
40,072 $2.01 2,141,903
(Direct)
View
2019-05-24
Exercise
2019-05-29
6:57 pm
2012-10-01
2022-09-28
ARROWHEAD PHARMACEUTICALS Inc ARWR Anzalone Christopher Richard
CEO
9,376 $2.62 2,141,903
(Direct)
View
2019-01-01
Option Award
2019-01-03
7:49 pm
N/A
N/A
ARROWHEAD PHARMACEUTICALS Inc ARWR Anzalone Christopher Richard
CEO
600,000 $0 2,142,455
(Direct)
View
2018-01-01
Option Award
2018-01-03
7:22 pm
N/A
N/A
ARROWHEAD PHARMACEUTICALS Inc ARWR Anzalone Christopher Richard
CEO
500,000 $0 2,294,789
(Direct)
View